This page is an index of presentations, PowerPoint slides by
Dr. Ashford
HOW CAN NEUROIMAGING HELP UNDERSTAND, DIAGNOSE, AND
DEVELOP TREATMENTS FOR ALZHEIMER'S DISEASE?
NUCLEAR MEDICINE GRAND ROUNDS,
Stanford University, January 5, 2010
Part A – AD definition, neuropathology (4.5 MB)
Part B – AD and brain systems (1.4 MB)
Part C – AD brain scans - anatomical (4.5 MB)
Part D1 – AD brain scans - perfusion -SPECT (5.6 MB)
Part D2 – AD brain scans – metabolism - PET (.5 MB)
Part E – AD and amyloid PET ligands (1.5 MB)
Part F – AD and biomarkers for the future (1.5 MB)
TESTING A LEPTIN PRODUCT AS A NOVEL THERAPY FOR ALZHEIMER’S DISEASE (3.9 MB)
2nd conference of Clinical Trials on Alzheimer’s Disease (CTAD)
Las Vegas, October 30, 2009
A Computerized/Web-Based Test to Assess the Continuum of
Normal Memory/Cognition to Dementia (4 MB)
American Association of Geriatric Psychiatry
Honolulu, Hawaii, March 6, 2009
Alzheimer’s Disease and Research Directions for Prevention
Redwood City Public Library, sponsord by Stanford Health Library
Redwood City, California, May 30, 2007
Statistical Issues for Developing Alzheimer Screening Tests.
Alzheimer's Association Prevention Conference,
Washington, D.C. 6/19/05
Screening
Elderly Clinic Patients for Early Dementia: Psychological Tests,
Brain Scans, Genetic Tests, and CSF Biomarkers. 7th Annual
Updates on Dementia, Stanford University Medical Center, 5/16/05
Stanford / VA Alzheimer Center talk on:
Mild Cognitive
Impairment, Differential Diagnosis - 5/14/2004
Alzheimer
Screening, Cost-Benefit Analysis - 10/8/2004
San Francisco,
CA - Recent Advances in Alzheimer's disease -
10/5/2004
---
---Handout-----
Calabasas,
CA - 10/14/2004
Geriatric
Psychiatry: Review and Update:
Medical and Neurologic
Aspects
American Association
of Geriatric Psychiatry, 2/24/02
Recent
Advances in Alzheimer's
Disease
Kentucky
Psychiatric Association - Keynote Address, 9/24/2002
(.1meg)
Delirium,
Dementia, and Amnestic and other Cognitive
Disorders
Second Year Medical
School, University of Kentucky, 2/12/2003
Neuropsychiatry
in the Nursing Home
Family
Medicine Review Course, University of Kentucky,
2001-2002
Alzheimer
Pathology and Neuroplasticity
Neurosci
Society 11/2002: Clinical AD Onset AD Earlier with APOE4
-
replaced with presentation to New York Academy of Sciences,
5/29/2003 - APOE Effects of Clinical Onset of AD,
Epidemiology, and Gompertzian Aging Functions
- see draft of paper
and Cincinnati debate
paper
TOP 10
TREATMENTS for preventing Alzheimer's disease (under
development)
ALZHEIMER
HYPOTHESIS (Ashford's Neuroplasticity
Hypothesis)